Cross-validation of optimized composites for preclinical Alzheimer's disease.

about

Power analysis to detect treatment effects in longitudinal clinical trials for Alzheimer's disease.EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5.

P2860

Q41502500-1C1D94A2-4249-4F15-9EAA-4F04FD9154BC Q46211759-79FD98E0-B3C0-49EE-B324-D5FC7884F3FA Q47141681-3BBA0BA5-E8AF-44D5-A6F4-A7E35C05BC6C

P2860

Cross-validation of optimized composites for preclinical Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q38373065

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cross-validation of optimized composites for preclinical Alzheimer's disease.

@en

type

Item

label

Cross-validation of optimized composites for preclinical Alzheimer's disease.

@en

prefLabel

Cross-validation of optimized composites for preclinical Alzheimer's disease.

@en

P1476

Cross-validation of optimized composites for preclinical Alzheimer's disease.

@en

P2093

AIBL

http://www.w3.org/2001/XMLSchema#string

AN-ADNI

http://www.w3.org/2001/XMLSchema#string

Chung-Kai Sun

http://www.w3.org/2001/XMLSchema#string

J-ADNI

http://www.w3.org/2001/XMLSchema#string

Philip S Insel

http://www.w3.org/2001/XMLSchema#string

Rema Raman

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline

Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE).

Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.

Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults

Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.

Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future.

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.

P304

123-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TRCI.2016.12.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul S. Aisen

Michael Donohue

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28758145

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5527287

http://www.w3.org/2001/XMLSchema#string

Cross-validation of optimized composites for preclinical Alzheimer's disease.

about

P2860

P2860

Cross-validation of optimized composites for preclinical Alzheimer's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932